NZ183687A - 7-arylmalonamido-1-oxadethiacephalosporins,pharmaceutical compositions and veterinary treatment - Google Patents

7-arylmalonamido-1-oxadethiacephalosporins,pharmaceutical compositions and veterinary treatment

Info

Publication number
NZ183687A
NZ183687A NZ183687A NZ18368777A NZ183687A NZ 183687 A NZ183687 A NZ 183687A NZ 183687 A NZ183687 A NZ 183687A NZ 18368777 A NZ18368777 A NZ 18368777A NZ 183687 A NZ183687 A NZ 183687A
Authority
NZ
New Zealand
Prior art keywords
arylmalonamido
oxadethiacephalosporins
pharmaceutical compositions
veterinary treatment
veterinary
Prior art date
Application number
NZ183687A
Other languages
English (en)
Inventor
W Nagata
M Narisada
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP3340176A external-priority patent/JPS52122386A/ja
Priority claimed from JP5029576A external-priority patent/JPS52133997A/ja
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of NZ183687A publication Critical patent/NZ183687A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D505/00—Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NZ183687A 1976-03-25 1977-03-24 7-arylmalonamido-1-oxadethiacephalosporins,pharmaceutical compositions and veterinary treatment NZ183687A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP3340176A JPS52122386A (en) 1976-03-25 1976-03-25 Cephalosporin analogous compounds as antibacterials
JP5029576A JPS52133997A (en) 1976-04-30 1976-04-30 Cephalosporin antibiotics

Publications (1)

Publication Number Publication Date
NZ183687A true NZ183687A (en) 1979-01-11

Family

ID=26372085

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ183687A NZ183687A (en) 1976-03-25 1977-03-24 7-arylmalonamido-1-oxadethiacephalosporins,pharmaceutical compositions and veterinary treatment

Country Status (19)

Country Link
AR (1) AR224606A1 (fr)
BG (1) BG31074A3 (fr)
CY (1) CY1158A (fr)
DD (1) DD129792A5 (fr)
DE (1) DE2713370C2 (fr)
DK (1) DK161331C (fr)
ES (5) ES457174A1 (fr)
GR (1) GR61146B (fr)
HK (1) HK46882A (fr)
HU (1) HU172720B (fr)
IE (1) IE44794B1 (fr)
IL (1) IL51743A (fr)
MX (1) MX4348E (fr)
NO (2) NO158505C (fr)
NZ (1) NZ183687A (fr)
PT (1) PT66346B (fr)
RO (2) RO71742A (fr)
SE (1) SE443143B (fr)
YU (2) YU44039B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1557552A (en) * 1977-02-15 1979-12-12 Shionogi & Co 1 oxadethiacepham compounds
US4252953A (en) * 1979-05-01 1981-02-24 Eli Lilly And Company Antibiotic crystalline epimer
JPS60123490A (ja) * 1983-12-07 1985-07-02 Shionogi & Co Ltd マロニルオキサセフェムカルボン酸誘導体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL178005C (nl) * 1972-11-06 1986-01-02 Merck & Co Inc Werkwijze voor het bereiden van een farmaceutisch preparaat met antibacteriele werking, alsmede werkwijze ter bereiding van een cefalosporine-antibioticum.
US3962232A (en) * 1973-11-05 1976-06-08 Eli Lilly And Company 7-methoxycephalosporins
GB1449420A (en) * 1973-11-26 1976-09-15 Sankyo Co 7alpha-methoxycephalosporing derivatives

Also Published As

Publication number Publication date
HU172720B (hu) 1978-11-28
NO862107L (no) 1977-09-27
YU44038B (en) 1990-02-28
ES469287A1 (es) 1979-09-16
IE44794L (en) 1977-09-25
RO71742A (fr) 1982-02-26
IE44794B1 (en) 1982-04-07
GR61146B (en) 1978-09-27
NO158505C (no) 1988-09-21
DE2713370A1 (de) 1977-09-29
SE7703325L (sv) 1977-09-26
RO78228A (fr) 1982-02-01
DE2713370C2 (de) 1994-04-21
AR224606A1 (es) 1981-12-30
ES457174A1 (es) 1978-08-16
HK46882A (en) 1982-11-19
ES469285A1 (es) 1979-09-16
DK161331C (da) 1991-12-09
YU44039B (en) 1990-02-28
ES469284A1 (es) 1978-11-16
MX4348E (es) 1982-04-05
NO771023L (no) 1977-09-27
CY1158A (en) 1983-01-28
NO158505B (no) 1988-06-13
BG31074A3 (en) 1981-10-15
DK161331B (da) 1991-06-24
DK131277A (da) 1977-09-26
SE443143B (sv) 1986-02-17
IL51743A (en) 1980-10-26
ES469286A1 (es) 1979-09-16
PT66346B (en) 1978-08-16
YU173783A (en) 1983-12-31
YU173883A (en) 1983-12-31
PT66346A (en) 1977-04-01
DD129792A5 (de) 1978-02-08

Similar Documents

Publication Publication Date Title
IL53063A (en) Phenoxy-amino-propanols,processes for their preparation and pharmaceutical compositions comprising them
NZ188626A (en) Acylanilides and pharmaceutical and veterinary compositions
NZ183616A (en) Acetohydroxamic derivatives,and pharmaceutical compositions
NZ185986A (en) 2-oxa-bicyclic prostag-landins and pharmaceutical compositions
NZ183551A (en) Aminochromanols and pharmaceutical compositions containingthem
NZ185358A (en) Spiro-hydantoins and pharmaceutical compositions
NZ185965A (en) 5'-deoxy-5-fluor ocytidine, 5'-deoxy-5-fluoro-uridine and pharmaceutical compositions
PH16512A (en) N-(phenylalkylamino-alkyl)-dihydroisoquinolinones,pharmaceutical compositions and methods employing them
PH13918A (en) Benzisothiazolone,antithrombotics and their pharmaceutical composition
NZ184428A (en) N-acyl-l-alanyl-aminoacyl-amides untermediates and pharmaceutical compositions
JPS5386038A (en) Pharmaceutical composition for animal and application
PH11669A (en) Thienobenzo(1,5)diazepine derivatives and the pharmaceutical formulation thereof
NZ184912A (en) 2-phenylamino-imidazolines and pharmaceutical compositions
NZ184187A (en) W-nor-aromatic-13,14-dehydro-prostaglandins pharmaceutical and veterinary compositions intermediates
MY8000099A (en) Isobutyramides, their preparation and therapeutic compositions containing them
NZ184102A (en) Derivatives of benzenesulphonylurea,and pharmaceutical compositions
NZ185539A (en) Cis-4a-aryl-2-substituted-2,3,4,4a,5,6,7,7a-octa hydro-1h-2-pyrindines and pharmaceutical compositions
PH12712A (en) Substituted s-alkylphenylisotrioureas,and their use as medicaments
NZ183549A (en) Amidinopencillanoyloxy-alkyl-amoxycillinates and pharmaceutical compositions
IL55018A (en) Benzylpyrimidines,their manufacture and pharmaceutical compositions containing them
NZ184185A (en) 3,5,5-trimethylhexanoyl-ferrocene and pharmaceutical compositions
PH15625A (en) Pyridazopyridazine derivatives,their pharmaceutical compositions and their use
NZ184714A (en) 2-alkoxy carbonylamino-5-phenyl-imidazoles, and pharmaceutical compositions
IL51866A0 (en) Pharmaceutical veterinary and cosmetic compositions containing fluoroacyltesorcins
NZ183687A (en) 7-arylmalonamido-1-oxadethiacephalosporins,pharmaceutical compositions and veterinary treatment